105
Participants
Start Date
June 30, 2012
Primary Completion Date
September 27, 2021
Study Completion Date
September 27, 2021
probiotic
Low-risk women, women with prior preeclampsia and women with a prior preterm birth will be randomized to be treated with LGG during pregnancy. Effect on maternal and perinatal outcome as well as the effect of treatment on immunological and inflammatory biomarkers will be evaluated.
placebo
Low-risk women, women with prior preeclampsia and women with a prior preterm birth will be randomized to be treated with placebo during pregnancy. Effect on maternal and perinatal outcome as well as the effect of treatment on immunological and inflammatory biomarkers will be evaluated.
Bo Jacobsson, Gothenburg
Sahlgrenska University Hospital
OTHER